Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...
Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...
To accelerate discovery, scientists from ATCC and the Broad Institute collaborated to engineer a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.
Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results